 |
Conference papers
First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model
Martine Dubois
1
Benjamin Quignon
1
Marie-Christine Tonon
1
Pierrick Gandolfo
1
Florence Joly
2
Hélène Castel
1
Martine Dubois 1
Author
Benjamin Quignon 1
Author
Marie-Christine Tonon 1
Author
Pierrick Gandolfo 1
Author
Florence Joly 2
Author
Hélène Castel 1
Author IdHAL : helene-castel ResearcherId : http://www.researcherid.com/rid/B-8675-2009 ORCID : https://orcid.org/0000-0002-8972-5555
1
DC2N - Différenciation et communication neuronale et neuroendocrine (Place Emile Blondel Faculté des Sciences et Techniques 76821 Mont-Saint-Aignan Cedex - France)
- UNIROUEN - Université de Rouen Normandie : U982 (1, rue Thomas Becket 76821 Mont-Saint-Aignan Cedex - France)
- NU - Normandie Université (Esplanade de la Paix - CS 14032 - 14032 Caen Cedex 5 - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U982 (101, rue de Tolbiac, 75013 Paris - France)
2
Service d'Oncologie médicale [CHU Caen] (Caen - France)
- CHU Caen (Avenue de la Côte de Nacre 14000 Caen - France)
- NU - Normandie Université (Esplanade de la Paix - CS 14032 - 14032 Caen Cedex 5 - France)
- TCBN - Tumorothèque de Caen Basse-Normandie (3 avenue du Général Harris 14076 Caen cedex 5 - France)
Document type :
Conference papers
Complete list of metadata
https://hal-normandie-univ.archives-ouvertes.fr/hal-02299483
Contributor : Hélène Castel Connect in order to contact the contributor
Submitted on : Friday, September 27, 2019 - 5:34:42 PM
Last modification on : Tuesday, October 19, 2021 - 4:15:43 PM
Contributor : Hélène Castel Connect in order to contact the contributor
Submitted on : Friday, September 27, 2019 - 5:34:42 PM
Last modification on : Tuesday, October 19, 2021 - 4:15:43 PM
Identifiers
- HAL Id : hal-02299483, version 1
Collections
Citation
Martine Dubois, Benjamin Quignon, Marie-Christine Tonon, Pierrick Gandolfo, Florence Joly, et al.. First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model. World Congress on Neurotherapeutics (DDDN), Sep 2014, Bâle, Switzerland. ⟨hal-02299483⟩
Metrics
Record views
